ask="1.9800"
ask_size="600"
average_daily_volume="596805"
bid="1.5400"
bid_size="3900"
book_value="-0.0870"
change="+0.0377"
change_from_200_day_moving_average="0.0867"
change_from_50_day_moving_average="0.1666"
change_from_52_week_high="-1.0823"
change_From_52_week_low="0.7577"
change_in_percent="+2.4641%"
close="1.5677"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.5480"
ebitda="-20.60M"
eps_estimate_current_year="-0.5900"
eps_estimate_next_quarter="-0.1500"
eps_estimate_next_year="-0.6400"
ex_dividend_date="N/A"
float_shares="55440000"
high="1.5711"
high_52_weeks="2.6500"
last_trade_date="2/10/2017"
last_trade_price="1.5677"
last_trade_size="1000"
last_trade_time="3:59pm"
low="1.4800"
low_52_weeks="0.8100"
market_capitalization="93.97M"
moving_average_200_day="1.4810"
moving_average_50_day="1.4011"
name="ContraVir Pharmaceuticals Inc"
notes="N/A"
one_year_target_price="4.5000"
open="1.5600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+5.8542%"
percent_change_from_50_day_moving_average="+11.8867%"
percent_change_from_52_week_high="-40.8415%"
percent_change_from_52_week_low="+93.5432%"
previous_close="1.5300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="59944000"
short_ratio="3.4300"
stock_exchange="NCM"
symbol="CTRV"
volume="702849"
weeks_range_52="0.8100 - 2.6500"
